Zoetis reported $1.07B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Align Technology USD 232.86M 3.72M Jun/2026
Bayer EUR 1.62B 529M Sep/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Dentsply International USD 146M 44M Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Henry Schein USD 321M 33M Sep/2026
Idexx Laboratories USD 447.35M 21.11M Sep/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
J&J USD 8.99B 721M Jun/2026
Laboratory Of America USD 674.3M 93.4M Sep/2026
Merck USD 1.42B 2.97B Jun/2026
Neogen USD 41.6M 3.8M Jun/2026
Pacira USD 50.45M 1.78M Sep/2026
Perrigo USD 156.6M 83M Sep/2026
Pfizer USD 6.36B 350M Sep/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Quest Diagnostics USD 627M 21M Sep/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Sanofi EUR 6.66B 4.99B Sep/2026
Zoetis USD 1.07B 21M Sep/2026